日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters

多抗原鼻内疫苗可预防沙贝病毒感染并阻止病毒在仓鼠体内传播。

Ankita Leekha # ,Arash Saeedi # ,K M Samiur Rahman Sefat ,Monish Kumar ,Melisa Martinez-Paniagua ,Adrian Damian ,Rohan Kulkarni ,Kate Reichel ,Ali Rezvan ,Shalaleh Masoumi ,Xinli Liu ,Laurence J N Cooper ,Manu Sebastian ,Courtney M Sands ,Vallabh E Das ,Nimesh B Patel ,Brett Hurst ,Navin Varadarajan

Machine Learning Models Identify Inhibitors of SARS-CoV-2

机器学习模型识别 SARS-CoV-2 抑制剂

Victor O Gawriljuk, Phyo Phyo Kyaw Zin, Ana C Puhl, Kimberley M Zorn, Daniel H Foil, Thomas R Lane, Brett Hurst, Tatyana Almeida Tavella, Fabio Trindade Maranhão Costa, Premkumar Lakshmanane, Jean Bernatchez, Andre S Godoy, Glaucius Oliva, Jair L Siqueira-Neto, Peter B Madrid, Sean Ekins

Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses

Boceprevir、钙蛋白酶抑制剂 II 和 XII 以及 GC-376 具有广谱抗冠状病毒活性

Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Boceprevir、GC-376 和钙蛋白酶抑制剂 II、XII 通过靶向病毒主蛋白酶来抑制 SARS-CoV-2 病毒复制

Chunlong Ma, Michael Dominic Sacco, Brett Hurst, Julia Alma Townsend, Yanmei Hu, Tommy Szeto, Xiujun Zhang, Bart Tarbet, Michael Thomas Marty, Yu Chen, Jun Wang

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L

SARS-CoV-2 主要蛋白酶的结构和抑制揭示了开发针对 Mpro 和组织蛋白酶 L 的双重抑制剂的策略

Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, Peter Dube, Xiujun Zhang, Yanmei Hu, Naoya Kitamura, Brett Hurst, Bart Tarbet, Michael Thomas Marty, Antonios Kolocouris, Yan Xiang, Yu Chen, Jun Wang

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro

IMU-838 是一种用于治疗自身免疫性疾病的处于 II 期研发中的 DHODH 抑制剂,体外表现出抗 SARS-CoV-2 和广谱抗病毒功效

Friedrich Hahn, Christina Wangen, Sigrun Häge, Antonia Sophia Peter, Gerhard Dobler, Brett Hurst, Justin Julander, Jonas Fuchs, Zsolt Ruzsics, Klaus Überla, Hans-Martin Jäck, Roger Ptak, Andreas Muehler, Manfred Gröppel, Daniel Vitt, Evelyn Peelen, Hella Kohlhof, Manfred Marschall

Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture

Boceprevir、钙蛋白酶抑制剂 II 和 XII 以及 GC-376 在细胞培养中对冠状病毒具有广谱抗病毒活性

Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang

Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L

SARS-CoV-2 主要蛋白酶的结构和抑制揭示了开发针对 Mpro 和组织蛋白酶 L 的双重抑制剂的策略

Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, Peter Dube, Xiujun Zhang, Yanmei Hu, Naoya Kitamura, Brett Hurst, Bart Tarbet, Michael Thomas Marty, Antonios Kolocouris, Yan Xiang, Yu Chen, Jun Wang